)
Zoetis (ZTS) investor relations material
Zoetis Barclays 28th Annual Global Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Fiscal 2025 performance and 2026 outlook
Achieved 6% organic operational revenue growth and 7% bottom-line growth in 2025, with stronger growth in the first half than the second half due to consumer pressures and competitive launches.
U.S. consumer weakness, especially among Gen Z and millennials, led to lower volumes but higher prices in pet care; livestock portfolio showed robust growth.
2026 guidance projects 3%-5% top-line growth and 3%-6% bottom-line growth, with livestock expected to outpace companion animal growth.
Price contributed just under 4% to 2025 growth, with volume accounting for about 2.5%; 2026 guidance assumes a balanced contribution from price and volume.
Diagnostics, though 4% of revenues, is growing faster than the overall business and will contribute to growth.
Diversification and international trends
U.S. accounts for 55% of total revenues, with international markets providing diversification and resilience against regional headwinds.
International companion animal business has grown at a similar rate to the U.S., with significant opportunities ahead, especially as innovation expands globally.
Livestock growth is driven by demand for animal protein, with aqua and poultry as the fastest-growing segments.
Key product segments and market dynamics
Parasiticides is a $7 billion global segment, with triple combinations like Trio becoming the standard in the U.S.; triple combinations now represent 50% of the market and are expected to reach two-thirds.
Trio delivered $1 billion in U.S. revenues in 2025, with significant expansion potential as market penetration increases.
Dermatology revenues reached $1.7 billion in 2025, with growth slowing in the second half due to competitive launches and fewer therapeutic visits, but long-term expansion opportunities remain.
Key franchises in derm, Simparica, and pain are expected to grow mid- to high-single digits in 2026.
- Strong product innovation and market expansion drive growth amid resilient pet health spending.ZTS
Leerink Global Healthcare Conference 20269 Mar 2026 - 2026 guidance reflects resilience, innovation, and a synchronized global reporting calendar.ZTS
BofA Securities Animal Health Summit26 Feb 2026 - 2025 saw 6% organic growth, robust franchises, and strong 2026 guidance for further gains.ZTS
Q4 202512 Feb 2026 - Strong Q1 growth, robust innovation pipeline, and expanding alternative channels drive outlook.ZTS
Stifel Jaws & Paws Conference 20253 Feb 2026 - Q2 revenue up 11% operationally, adjusted net income up 18%, and $6B buyback approved.ZTS
Q2 20242 Feb 2026 - Strong Q1 growth in companion animal products drives raised guidance and sustained momentum.ZTS
The 44th Annual William Blair Growth Stock Conference31 Jan 2026 - Innovation, channel growth, and margin expansion fuel strong performance and future outlook.ZTS
Morgan Stanley 22nd Annual Global Healthcare Conference22 Jan 2026 - Q3 2024 delivered double-digit growth, driven by innovation in companion animal and livestock portfolios.ZTS
Q3 202417 Jan 2026 - Q3 saw robust double-digit growth across all key franchises, with strong momentum into 2025.ZTS
Jefferies London Healthcare Conference 202413 Jan 2026
Next Zoetis earnings date
Next Zoetis earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage